Organon (OGN) Change in Accured Expenses (2020 - 2026)

Organon's Change in Accured Expenses history runs 7 years deep, the most recent figure standing at $95.0 million for Q1 2026.

• In Q1 2026, Change in Accured Expenses rose 143.59% year-over-year to $95.0 million; the TTM figure through Mar 2026 stood at -$86.0 million (down 82.98% YoY), while the FY2025 annual figure was -$142.0 million, down 40.59% from the prior year.
• Change in Accured Expenses was $95.0 million for Q1 2026 at Organon, up from -$156.0 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $165.0 million in Q3 2023 to a low of -$156.0 million in Q4 2025.
• Historically, Change in Accured Expenses has averaged $7.4 million across 5 years, with a median of -$8.0 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Change in Accured Expenses plunged 950.0% in 2023, then surged 360.0% in 2025.
• A 5-year view of Change in Accured Expenses shows it stood at $64.0 million in 2022, then climbed by 6.25% to $68.0 million in 2023, then sank by 207.35% to -$73.0 million in 2024, then tumbled by 113.7% to -$156.0 million in 2025, then soared by 160.9% to $95.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $95.0 million (Q1 2026), -$156.0 million (Q4 2025), and $73.0 million (Q3 2025), per Business Quant data.